Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders.

Autor: Harrington P; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; School of Cancer and Pharmaceutical Science, King's College London, London, United Kingdom., Kurshan A; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom., Delord M; Department of Population Health Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Lechmere T; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom., Sheikh A; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Saunders J; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Saha C; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Dillon R; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Department of Medicine and Molecular Genetics, King's College London, London, United Kingdom., Woodley C; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Asirvatham S; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Curto-Garcia N; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Sullivan JO; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Kordasti S; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; School of Cancer and Pharmaceutical Science, King's College London, London, United Kingdom., Radia D; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., McLornan D; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Department of Clinical Haematology, University College Hospital, London, United Kingdom., Malim MH; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom., Harrison C; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; School of Cancer and Pharmaceutical Science, King's College London, London, United Kingdom., Doores KJ; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom., de Lavallade H; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; School of Cancer and Pharmaceutical Science, King's College London, London, United Kingdom.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2023 May 23; Vol. 7 (10), pp. 1954-1957.
DOI: 10.1182/bloodadvances.2022008375
Databáze: MEDLINE